$539.98
-4.64-0.85%
Last update: Jun 2, 9:30 AM
United Therapeutics Corp Earnings Estimates
UTHRNASDAQ
United Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:UTHR
United Therapeutics (UTHR) is scheduled to report Q2 earnings on July 29, 2026. Analysts estimate EPS of $6.94 and quarterly revenue of $809.90M.
In the most recent quarter (Q1), United Therapeutics reported EPS of $5.82, missing estimates of $6.83 by 0.15%. Revenue came in at $781.50M, missing the estimate of $797.97M by 0.02%.
Over the last 4 quarters, United Therapeutics has averaged an EPS surprise of 0.10% and a revenue surprise of 0.02%.
Earnings Date
Jul 29
EPS Estimate
$6.940
Quarterly Revenue Estimate
$809.90M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$3.17B
United Therapeutics Earnings History
Analyze the earnings history of United Therapeutics using advanced sorting and filters.
Loading calendar...
United Therapeutics (UTHR) Earnings Per Share
The chart below shows United Therapeutics's reported EPS compared to analyst estimates over recent quarters.
United Therapeutics (UTHR) Revenue
The chart below shows United Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is United Therapeutics (NASDAQ:UTHR) reporting earnings?
United Therapeutics (UTHR) is scheduled to report earnings on July 29, 2026. The last reported earnings were for reported on May 6, 2026 for Q1.
What were the latest earnings per share (EPS) for United Therapeutics (NASDAQ:UTHR)?
The Actual EPS was $5.82, which missed the estimate of $6.83.
What were United Therapeutics’s (NASDAQ:UTHR) revenues?
The Actual Revenue was $781.50M, which missed the estimate of $797.97M.
